Spray Drying Market Poised To Nearly Double By 2033

By Katie Anderson, Chief Editor, Pharmaceutical Online

The pharmaceutical spray drying market is anticipating some serious growth, according to a recent market report by Precedence Research. Valued at $2.56 billion in 2025, the market is expected to have a 7.68% CAGR to reach $4.63 billion by 2033.

The growth of the spray drying market is attributed to demand for enhanced stability, bioavailability and solubility of poorly soluble drugs. The growth is also due to growing rates of chronic diseases, more complex therapeutics and more regulatory support for novel drugs.

Technology Leaders

Small molecule oral drugs, specifically those in powder form, led this market with a majority share. This formulation type is stable, soluble and easy to administer. These drugs can be produced in high volume, and though batch manufacturing still leads the market, continuous manufacturing is projected to aid in its growth. The portion of small molecule drugs for chronic diseases also require the improved bioavailability of spray drying technology.

Of the spray drying technologies utilized in pharmaceutical manufacturing, the two-fluid nozzle segment held the largest share. Not only is it affordable, but it is also versatile in application and accurate in particle size.

Regional Leaders

When it comes to geographical leaders in pharmaceutical spray drying, North America holds the largest share of the market with 37.20%. North America has a large contingency of pharmaceutical manufacturers. It also has a rising rate of chronic disease and a high level of R&D in the field to support innovation

Although North America is in the lead, Europe is not far behind with 28.7%. Though Asia-Pacific is in third with 23.4%, it is expected to grow the most over the coming years to be a leader in the segment. Asia-Pacific is the location of a vast population of CMOs, and heath care investments are increasing in the continent.